Company
SystImmune Inc.
SystImmune Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| T-Bren, Dose level 1 | Phase 3 | Urothelial Cancer |
Latest
No recent events.
Follow SystImmune Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.